Dianthus Therapeutics, Inc. (DNTH) earnings
Quarterly results of Dianthus Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Dianthus Therapeutics, Inc. was expected to report around October 15, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Dianthus Therapeutics, Inc. reported revenue of - and a net loss of $50.2M.
Diluted earnings per share were -$0.90.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$50.2M | -$0.90 |
| Q1 FY2026 | - | - | -$40.8M | -$0.85 |
| Q4 FY2025 | $284K | -78.6% | -$64.4M | - |
| Q3 FY2025 | $396K | -81.8% | -$36.8M | -$0.97 |
| Q2 FY2025 | $193K | - | -$31.6M | -$0.88 |
| Q1 FY2025 | $1.2M | - | -$29.5M | -$0.82 |
| Q4 FY2024 | $1.3M | - | -$28.4M | - |
| Q3 FY2024 | $2.2M | - | -$25.2M | -$0.74 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is Dianthus Therapeutics, Inc.'s next earnings date?
Dianthus Therapeutics, Inc. was expected to report around October 15, 2026; nothing is on file with the SEC yet.
Get an email when DNTH reports
Follow DNTH and we email you its next results the day they are filed, with the numbers explained.